Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
University of Southern California
Seattle Children's Hospital
Valo Therapeutics Oy
Epkin
University of Iowa
Corvus Pharmaceuticals, Inc.